Skip to content
Lately the world is enraptured with AI and its potential to change our lives. AI transforms our digital world—the world of information. But changing lives […]
Dr. Jason Kelly: Teaming up to build our bio future Read More »
To ensure national security in the face of potential biological threats, the U.S. government relies on a partnership with biotech firms, federal officials explained
BIO 2024: U.S. officials describe national security partnership with biotech Read More »
The 2024 BIO International Convention, hosted by the Biotechnology Innovation Organization (BIO), begins today, June 3, in San Diego. It’s not so sunny—yet—but the
We’re live from BIO 2024 in San Diego Read More »
Is the accelerated approval pathway helping patients achieve better health outcomes or imposing on society medicines that don’t work? In BIO’s view, the pathway
Setting the record straight on accelerated approval Read More »
Sen. Bernie Sanders (I-Vt.), Chair of the Senate Health, Education, Labor, and Pensions Committee, announced that he is launching an investigation into the pricing
On April 18, BIO’s inaugural Agriculture & Environment Summit brought together bipartisan policymakers who emphasized the promise of innovation to address key challenges such
BIO Agriculture & Environment Summit brings together bipartisan policymakers, regulators Read More »
A recent human infection of avian flu in Texas, coming just days after the first infections of U.S. livestock, has spurred research into the
Biotech and One Health are key to controlling avian flu Read More »
Clear laws giving intellectual property rights to human inventors who use artificial intelligence will allow us to take advantage of the remarkable advances AI
People invent things – AI just helps, biotech IP expert tells Congress Read More »
The Inflation Reduction Act (IRA) is expected to have broad negative impacts on patients, most notably through less access to future cures and treatments.
Heart disease patients and the IRA’s misguided incentives Read More »
The COVID-19 pandemic laid bare the vulnerabilities of global supply chains, especially in the biopharmaceutical sector. “Nobody ever could have envisioned a global pandemic
Why building America’s biomanufacturing sector is critical for America’s security Read More »
